Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis

Stem Cells Translational Medicine

Volumn 2, Issue 10, 2013, Pages 789-796

  Semon, Julie A ^a   Zhang, Xiujuan ^a   Pandey, Amitabh C ^a   Alandete, Sandra M ^a   Maness, Catherine ^b   Zhang, Shijia ^a   Scruggs, Brittni A ^a   Strong, Amy L ^a   Sharkey, Steven A ^a   Beuttler, Marc M ^a   Gimble, Jeffrey M ^c   Bunnell, Bruce A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipose; Adult stem cells; Neuroimmune; Stem cells; Tissue specific stem cells

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD14 ANTIGEN; CD146 ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXP3; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

MURINAE; MUS;

EID: 84884732167     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0032     Document Type: Article

References (46)

1. Vlahiotis A, Sedjo R, Cox ER et al. Gender differences in self-reported symptom awareness and perceived ability tomanagetherapy with disease-modifying medication among commercially insured multiple sclerosis patients. J Manag Care Pharm 2010;16:206-216.
2. The MS disease-modifying medications. Available at http://www.nationalmssociety. org. Accessed April 11, 2012.
3. Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: Role in metabolism and disease. Nat Rev Endocrinol 2010;6:195-213.
4. Kilroy GE, Foster SJ, Wu X et al. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212:702-709.
5. Peinado JR, Pardo M, de la Rosa O et al. Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity. Proteomics 2012;12:607-620.
6. Hausman GJ. Techniques for studying adipocytes. Stain Technol 1981;56:149-154.
7. Pettersson P, Cigolini M, Sjöström L et al. Cells in human adipose tissue developing into adipocytes. Acta Med Scand 1984;215:447-451.
8. Caspar-Bauguil S, Cousin B, Galinier A et al. Adipose tissues as an ancestral immune organ: Site-specific change in obesity. FEBS Lett 2005;579:3487-3492.
9. Casteilla L, Planat-Bénard V, Cousin B et al. Plasticity of adipose tissue: A promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Arch Mal Coeur Vaiss 2005;98:922-926.
10. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
11. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010;1:19.
12. Schäffler A, Büchler C. Concise review: Adipose tissue-derived stromal cells: Basic and clinical implications for novel cell-based therapies. Stem Cells 2007;25:818-827.
13. Danoviz ME, Bassaneze V, Nakamuta JS et al. Adipose tissue-derived stem cells from humans and mice differ in proliferative capacity and genome stability in long-term cultures. Stem Cells Dev 2011;20:661-670.
14. Kern S, Eichler H, Stoeve J et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301.
15. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells: Their utility and potential in bone formation. Int J Obes Relat Metab Disord 2000;24(suppl 4):S41-S44.
16. Planat-Benard V, Silvestre JS, Cousin B et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004;109: 656-663.
17. Rangappa S, Fen C, Lee EH et al. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003;75:775-779.
18. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7:211-228.
19. Majumdar MK, Banks V, Peluso DP et al. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000; 185:98-106.
20. Konno M, Hamazaki TS, Fukuda S et al. Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem Biophys Res Commun 2010;400:461-465.
21. Xu Y, Malladi P, Wagner DR et al. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 2005;7:300-305.
22. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
23. Sakaguchi Y, Sekiya I, Yagishita K et al. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-2529.
24. De Ugarte DA, Morizono K, Elbarbary A et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-109.
25. Izadpanah R, Trygg C, Patel B et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006;99:1285-1297.
26. Bredeson C, Leger C, Couban S et al. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 2004;10:405-414.
27. D'Andrea F, De Francesco F, Ferraro GA et al. Large-scale production of human adipose tissue from stem cells: A new tool for regenerative medicine and tissue banking. Tissue Eng Part C Methods 2008;14:233-242.
28. Casteilla L, Dani C. Adipose tissue-derived cells: From physiology to regenerative medicine. Diabetes Metab 2006;32:393-401.
29. Lombardo E, DelaRosa O, Mancheño-Corvo P et al. Toll-like receptor-mediated signaling in human adipose-derived stem cells: Implications for immunogenicity and immunosuppressive potential. Tissue Eng Part A 2009; 15:1579-1589.
30. Riordan NH, Ichim TE, Min WP, et al. Nonexpanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 2009;7:29.
31. Tafreshi AP, Mostafavi H, Zeynali B. Induction of experimental allergic encephalomyelitis in C57/BL6 Mice: An animal model for multiple sclerosis. Iran J Allergy Asthma Immunol 2005;4:113-117.
32. Racke MK. Experimental autoimmune encephalomyelitis (EAE). Curr Protoc Neurosci 2001;Chapter 9:Unit 9.7.
33. Bai L, Lennon DP, Eaton V et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009;57: 1192-1203.
34. Barhum Y, Gai-Castro S, Bahat-Stromza M et al. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci 2010;41: 129-137.
35. Rafei M, Campeau PM, Aguilar-Mahecha A et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009;182:5994-6002.
36. Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755-1761.
37. Gordon D, Pavlovska G, Glover CP et al. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci Lett 2008;448:71-73.
38. Constantin G, Marconi S, Rossi B et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009;27:2624-2635.
39. Chen SJ, Wang YL, Fan HC et al. Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis. Clin Dev Immunol 2012;2012: 970789
40. Reynolds JM, Martinez GJ, Chung Y et al. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci USA 2012;109:13064-13069.
41. Kassis I, Grigoriadis N, Gowda-Kurkalli B et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008;65:753-761.
42. Gerdoni E, Gallo B, Casazza S et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007;61:219-227.
43. Lanz TV, Opitz CA, Ho PP et al. Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells Dev 2010;19:657-668.
44. Han KH, Ro H, Hong JH et al. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transpl Immunol 2011;25:7-15.
45. Wehner R, Taubert C, Mende T et al. Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro. J Tissue Eng Regen Med 2012 [Epub ahead of print].
46. Carrión F, Nova E, Luz P et al. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation. Immunol Lett 2011; 135:10-16.